Bridge the gap between protocol and promotion.
Our Inspiration
“If I had asked people what they wanted, they would have said faster horses.”
- Henry Ford
While it’s a good starting point, it’s not enough to ask physicians which results they want to see when making treatment decisions.
But once it’s in the protocol, it’s too late.
Our Approach
We help companies to start thinking about how they intend to market their new drug from the very start.
Primary endpoints are often dictated by disease, drug-class standards, or the FDA. So, the opportunities lie in HOW the primary endpoint is measured, as well as the secondary and exploratory endpoint selections.
As marketers, we eat, sleep, and breathe that strategy, so it just makes sense to bring us into that process from the beginning.
Our Challenge
By the time the data gets to the marketing team and advertising agency, the marketers are trying to pull as much compelling data out of the draft label as possible.
With so many decisions having already been made, any ability to remain competitive in messaging and content is drastically limited.
The traditional way isn’t always the most effective way.
Our Value
By ensuring the marketing mindset is included in the conversation earlier, we can optimize the promotional brand story down the line.
We can get closer to saying what we want and truly set the drug apart from the competitors in the space.
Pharmalogix bridges the gap between protocol
and promotion.